About Us

Our Vision

End Hep C SF envisions a San Francisco where hepatitis C is no longer a public health threat, and hepatitis C related health inequities have been eliminated.

Our Mission

To support all San Franciscans living with and at risk for hepatitis C to maximize their health and wellness. We achieve this through prevention, education, testing, treatment, and linkage to reduce morbidity and mortality related to hepatitis C.

Our Values

We have based our work on beliefs that:

  • All people living with hepatitis C deserve access to the most effective treatment.
  • Everyone living with or at risk for hepatitis C should have equal access to prevention and care regardless of individual characteristics, including but not limited to race/ethnicity, insurance status, housing status, gender identity, sexual orientation, age, mental health status and substance use.
  • Our work is most effective when people who have lived experience with hepatitis C are involved in all aspects of planning and implementation.
  • It is imperative to draw on the wisdom of service providers, activists, people who use drugs, and others in the community who have been most impacted and engaged in the fight against hepatitis C over many years.

We are committed to working together to:

  • Provide interventions that are evidence based, and continuously review our progress to determine areas where we need to improve, through the regular collection of and use of local data related to hepatitis C.
  • End stigma about hepatitis C and people living with hepatitis C.
  • Maximize the health and wellness of people who use drugs by treating them with respect, ensuring access to appropriate services, and empowering them to reduce harm and make choices to improve their health.
  • Continue to invest in populations that have frequently been characterized as “difficult to engage,” as we realize that these groups often have the greatest unmet need for services and support.

Our Community

End Hep C SF is guided by a Coordinating Committee and four topic-specific work groups that recommend action steps to the Coordinating Committee. The Work Groups are comprised of individuals affected by HCV, healthcare and social service providers, community advocates, health department representatives, and other stakeholders.

Our Coordinating Committee

The Coordinating Committee is comprised of people who have expertise around hepatitis C and share the vision of hepatitis C elimination. Members represent several organizations and practices in San Francisco that are on the forefront of hepatitis C testing, linkage, treatment, and advocacy.

Current members of the Coordinating Committee include:

Name Organization Role
Katie Burk, MPH SFDPH Backbone Support
Shelley Facente, MPH Facente Consulting Facilitation
Sonya Dublin, MPH, MSW Facente Consulting Facilitation
Janelle Silvis Glide Foundation Prevention, Testing & Linkage Workgroup Representative
Joanna Eveland, MD SFDPH/Tom Waddell Urban Health Prevention, Testing & Linkage Workgroup Representative
Pauli Gray SFAF Prevention, Testing & Linkage Workgroup Representative
Perry Rhodes AHP Prevention, Testing & Linkage Workgroup Representative
Annie Luetkemeyer, MD UCSF/Positive Health Practice Treatment Access Workgroup Representative
Kelly Eagen, MD SFDPH Treatment Access Workgroup Representative
Meghan Morris, PhD UCSF/UFO Study Research & Surveillance Workgroup Representatives
Melissa Sanchez, PhD SFDPH Research & Surveillance Workgroup Representatives
Alfredta Nesbitt Bayview Hunters Point Foundation Methadone Program Liaison
Emalie Huriaux, MPH Project Inform Communications Liaison
Robin Roth SF Hep C Task Force SF Hep C Task Force Liaison
Isaac Jackson Urban Survivors Union Drug User Health Community Liaison

Our Work Groups

Work groups are open to the public. We welcome anyone with lived experience with hepatitis C, people who work on hepatitis C related issues professionally, and anyone who wants to learn more about hepatitis C. To learn more about the initiative or to get involved email Katie Burk.  You can also download our Vision Statement and Sign-On Sheet.

Research and Surveillance

The Research and Surveillance work group is comprised of researchers and epidemiologists who work on studies and surveillance related to hepatitis C. This group is broaching the question of how to best combine resources and information to understand the hepatitis C burden in San Francisco and to measure the progress we make towards eliminating hepatitis C.

This work group meetings every second Thursday of the month from 3:00-4:30 pm at 25 Van Ness, 5th floor conference room.  All are welcome. Email Katie Burk (katie.burk@sfdph.org) for more information.

Prevention, Testing, and Linkage

The Prevention, Testing, and Linkage work group is comprised of people who work for agencies that offer HCV prevention (syringe access and/or opiate replacement therapy) and/or community-based hepatitis C testing and linkage services. This groups addresses the issues of prevention HCV transmission among folks at risk, as well as how to identify and support marginalized San Franciscans who are most at risk for hepatitis C, yet among the least likely to be connected to services.

This work group meets the first Friday of the every month from 1:00-2:30 pm at 25 Van Ness, 5th floor conference room. All are welcome. Email Katie Burk (katie.burk@sfdph.org) for more information.

Treatment Access

This work group is largely comprised of clinicians, pharmacists, and other direct service staff. This group focuses on initiatives to improve access to hepatitis C treatments for San Franciscans who receive care in both the public and private sectors. Another large focus of this group includes innovative treatment delivery mechanisms for patients in substance use treatment facilities, shelters, and occupancy hotels.

The Treatment Access work group meets every second Friday of each month from 1:00-2:30 at the Ward 84 conference room of Zuckerberg San Francisco General. All are welcome. Email Katie Burk (katie.burk@sfdph.org) for more information.

Send us a line